日本語English简体中文 繁體中文

4587 PeptiDream Inc.ペプチドリームTSE Prime / Pharmaceuticals

0 posts

PeptiDream Inc. (4587) at a glance

Code
4587
Company
PeptiDream Inc.
Local name
ペプチドリーム
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥1,060 -50.0 (-4.50%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

PeptiDream Inc. (4587) Stock Price History

PeptiDream Inc. closed at ¥1,060 on Nov 20, 2026, +1.6% over 1 month, −35.4% over 1 year.

2026-11-11 2026年12月期第3四半期決算短信〔IFRS〕(連結)¥1,143¥1,039Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥1,143Nov 5
1-Month Low¥1,039Nov 6
1-Week Change−0.5%vs Nov 13
1-Month Change+1.6%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥101,581 today (+1.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved +1.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,060−50−4.50%
Nov 19 (Thu)¥1,110+21+1.93%
Nov 18 (Wed)¥1,089−33−2.94%
Nov 17 (Tue)¥1,122+33+3.03%
Nov 16 (Mon)¥1,089+24+2.25%
Nov 13 (Fri)¥1,065−16−1.48%
Nov 12 (Thu)¥1,081+6+0.56%
Nov 11 (Wed)¥1,075−32−2.89%
Nov 10 (Tue)¥1,107+24+2.22%
Nov 9 (Mon)¥1,083+44+4.23%
2026-11-11 2026年12月期第3四半期決算短信〔IFRS〕(連結)¥1,143¥1,031Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥1,143Nov 5
3-Month Low¥1,031Oct 15
1-Month Change+1.6%vs Oct 20
3-Month Change−3.8%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥96,232 today (−3.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −3.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,060−50−4.50%
Nov 19 (Thu)¥1,110+21+1.93%
Nov 18 (Wed)¥1,089−33−2.94%
Nov 17 (Tue)¥1,122+33+3.03%
Nov 16 (Mon)¥1,089+24+2.25%
Nov 13 (Fri)¥1,065−16−1.48%
Nov 12 (Thu)¥1,081+6+0.56%
Nov 11 (Wed)¥1,075−32−2.89%
Nov 10 (Tue)¥1,107+24+2.22%
Nov 9 (Mon)¥1,083+44+4.23%
2026-11-11 2026年12月期第3四半期決算短信〔IFRS〕(連結)¥1,216¥925May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥1,216May 22
6-Month Low¥925Jun 15
3-Month Change−3.8%vs Aug 20
6-Month Change−8.7%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥91,340 today (−8.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −8.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,060−5.1%
Oct 2026¥1,117+0.3%
Sep 2026¥1,114+2.2%
Aug 2026¥1,090+15.1%
Jul 2026¥947−11.0%
Jun 2026¥1,065−3.8%
May 2026¥1,107−3.8%
2026-11-11 2026年12月期第3四半期決算短信〔IFRS〕(連結)¥1,783¥925Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥1,783Jan 16
52-Week Low¥925Jun 15
Year to Date−36.0%vs Dec 30
From 52-Week High−40.5%Jan 16

If you had invested ¥100,000 1 year ago, it would be worth ¥64,614 today (−35.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −35.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,060−5.1%
Oct 2026¥1,117+0.3%
Sep 2026¥1,114+2.2%
Aug 2026¥1,090+15.1%
Jul 2026¥947−11.0%
Jun 2026¥1,065−3.8%
May 2026¥1,107−3.8%
Apr 2026¥1,151−3.9%
Mar 2026¥1,198−16.0%
Feb 2026¥1,426−8.9%
Jan 2026¥1,564−5.6%
Dec 2025¥1,657−6.9%
Nov 2025¥1,780―
¥2,950¥933Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥2,950Oct 14, 2024
3-Year Low¥933Jun 12, 2026
Annualized Return−5.0%
Max Drawdown−68.4%

If you had invested ¥100,000 3 years ago, it would be worth ¥85,830 today (−14.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −14.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,060−36.0%
2025¥1,657―
¥2,950¥933Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,950Oct 14, 2024
5-Year Low¥933Jun 12, 2026
Annualized Return−17.8%
Max Drawdown−68.4%

If you had invested ¥100,000 5 years ago, it would be worth ¥37,642 today (−62.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −62.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,060−36.0%
2025¥1,657―
¥6,110¥764Jul 1, 2013Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥6,110Jul 2019
All-Time Low¥764Apr 2014
Total Change+11.0%vs Jul 2013
Annualized Return+0.8%

If you had invested ¥100,000 in Jul 2013, it would be worth ¥110,995 today (+11.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +290.4%, while this stock moved +11.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,060−36.0%
2025¥1,657−37.4%
2024¥2,645+77.9%
2023¥1,487−28.4%
2022¥2,077−18.4%
2021¥2,545−51.4%
2020¥5,240−6.4%
2019¥5,600+29.0%
2018¥4,340+12.4%
2017¥3,860+27.0%
2016¥3,040+56.9%
2015¥1,938+46.6%
2014¥1,321−23.8%
2013¥1,735―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jul 2013). Please check the latest prices before trading.

PeptiDream Inc. (4587) financial indicators

PBR
2.83
Dividend yield
0.00%

See all financial indicators for PeptiDream Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of PeptiDream Inc. (4587)

Business overview

The company runs a drug discovery and development business using PDPS, its own drug discovery platform system, and a radiopharmaceutical business through wholly owned subsidiary 「PDRファーマ」. The drug discovery business uses drug discovery technologies centered on PDPS for joint drug discovery research and development, technology licensing of PDPS and expanding its own pipeline through strategic partnerships. The radiopharmaceutical business researches, develops, makes and sells diagnostic radiopharmaceuticals (diagnostic agents for SPECT and PET) that examine lesions such as cancer and abnormal accumulations in the brain through imaging, and therapeutic radiopharmaceuticals that meet unmet medical needs, mainly in oncology. In Japan it sells products such as sodium iodide capsules used to treat thyroid conditions and 「ライアットMIBG-I131静注」 used for pheochromocytoma and other conditions.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.83xAbove the sector median of 1.86x (No. 54 from the lowest)
Market cap¥136.3 bnNo. 21 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1,7831/16
52-week low¥9256/15
Current position15.7%Where the low is 0% and the high is 100% (close on 11/20: ¥1,060)
Year to date-36.0%No. 60 of 77 in the sector (best first)
1 year-35.4%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 losers1 timesLatest: 10/2 (No. 40)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the PeptiDream Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English